THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS.
D000614:Aminocaproates; D015119:Aminocaproic Acid; D001778:Blood Coagulation Disorders; D001780:Blood Coagulation Tests; D004358:Drug Therapy; D005342:Fibrinolysis; D005853:Geriatrics; D006801:Humans; D008297:Male; D011134:Polysaccharides; D011135:Polysaccharides, Bacterial; D011471:Prostatic Neoplasms; D011506:Proteins / Q000378:metabolism*; D059748:Proteolysis; D013917:Thrombin; D013918:Thrombin Time
D000614:Aminocaproates; D011134:Polysaccharides; D011135:Polysaccharides, Bacterial; D011506:Proteins; D013917:Thrombin; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; DRUG THERAPY; GERIATRICS; POLYSACCHARIDES, BACTERIAL; PROSTATIC NEOPLASMS; PROTEIN METABOLISM DISORDERS; THROMBIN